HYBRID BIOMATERIALS FOR ENGINEERING VASCULAR TISSUES - Biologically-Responsive Hybrid Biomaterials - page 373

[16] Hoerstrup, S.P., et al., “Tissue Engineering of Small Caliber Vascular Grafts,” European
Journal of Cardiothoracic Surgery , Vol. 20, No. 1, 2001, pp. 164-169.
[17] Berglund, J.D., et al., “A Biological Hybrid Model for Collagen-Based Tissue Engineered
Vascular Constructs,” Biomaterials , Vol. 24, No. 7, 2003, pp. 1241-1254.
[18] Wu, H.C., et al., “Coculture of Endothelial and Smooth Muscle Cells on a Collagen
Membrane in the Development of a Small-Diameter Vascular Graft,” Biomaterials , Vol. 28,
No. 7, 2007, pp. 1385-1392.
[19] Tschoeke, B., et al., “Tissue-Engineered Small-Caliber Vascular Graft Based on a Novel
Biodegradable Composite Fibrin-Polylactide Scaffold,” Tissue Engineering Part A , Vol. 15,
No. 8, 2009, pp. 1909-1918.
[20] Lei, Y., et al., “Therapeutic Angiogenesis: Devising New Strategies Based on Past
Experiences,” Basic Research in Cardiology , Vol. 99, No. 2, 2004, pp. 121-132.
[21] Ko, H.C., B.K. Milthorpe, and C.D. McFarland, “Engineering Thick Tissues - The
Vascularisation Problem,” European Cells & Materials, Vol. 14, 2007, pp. 1-19.
[22] Kaully, T., et al., “Vascularization - The Conduit to Viable Engineered Tissue,” Tissue
Engineering Part B , Vol. 15, No. 2, 2009, pp. 159-169.
[23] Kaehler, J., et al., “Precoating Substrate and Surface Configuration Determine Adherence and
Spreading of Seeded Endothelial Cells on Polytetrafluoroethylene Grafts,” Journal of
Vascular Surgery , Vol. 9, No. 4, 1989, pp. 535-541.
[24] Sugawara, Y., et al., “Rapid Post-Incubation Endothelial Retention by Dacron Grafts,”
Journal of Surgical Research , Vol. 67, No. 2, 1997, pp. 132-136.
[25] Bhat, V., et al., “Improving Endothelial Cell Adhesion to Vascular Graft Surfaces: Clinical
Need and Strategies,” Journal of Biomaterials Science, Polymer Edition , Vol. 9, No. 11,
1998, pp. 1117-1135.
[26] Haralson, M.A., and J.R. Hassell, “The Extracellular Matrix: An Overview.” In Extracellular
Matrix: A Practical Approach , pp. 1-30, Haralson, M.A., and J.R. Hassell (eds.), New York:
Oxford University Press, 1995.
[27] Lutolf, M.P., and J.A. Hubbell, “Synthetic Biomateials as Instructive Extracellular
Microenvironments for Morphogenesis in Tissue Engineering,” Nature Biotechnology , Vol.
23, No. 1, 2005, pp. 47-55.
[28] Blindt, R., et al., “A Novel Drug-Eluting Stent Coated with an Integrin-Binding Cyclic Arg-
Gly-Asp Peptide Inhibits Intimal Hyperplasia by Recruiting Endothelial Progenitor Cells,”
Journal of the American College of Cardiology , Vol. 47, No. 9, 2006, pp. 1786-1795.
[29] Alobaid, N., et al., “Nanocomposite Containing Bioactive Peptides Promote
Endothelialisation by Circulating Progenitor Cells: An In Vitro Evaluation,” European
Journal of Vascular & Endovascular Surgery , Vol. 32, No. 1, 2006, pp. 76-83.
[30] Veleva, A.N., S.L. Cooper, and C. Patterson, “Selection and Initial Characterization of Novel
Peptide Ligands that Bind Specifically to Human Blood Outgrowth Endothelial Cells,”
Biotechnology and Bioengineering , Vol. 98, No. 1, 2007, pp. 306-312.
[31] Veleva, A.N., D. E. Heath, S.L. Cooper, and C. Patterson, “Selective Endothelial Cell
Attachment to Peptide-Modified Terpolymers,” Biomaterials , Vol. 29, No. 27, 2008, pp.
3656-3661.
[32] Asahara, T., et al., “Isolation of Putative Progenitor Endothelial Cells for Angiogenesis,”
Science , Vol. 275, No. 5302, 1997, pp. 964-967.
[33] Gulati, R., et al., “Diverse Origin and Function of Cells with Endothelial Phenotype Obtained
from Adult Human Blood,” Circulation Research , Vol. 93, No. 11, 2003, pp. 1023-1025.
[34] Rehman, J., et al., “Peripheral Blood “Endothelial Progenitor Cells” are Derived from
Monocyte/Macrophages and Secrete Angiogenic Growth Factors,” Circulation , Vol. 107, No.
8, 2003, pp. 1164-1169.